Methods of treating viral diseases with il-18 and il-18 combinations
OwnerKlaus M Esser, Martin Rosenberg +4inventors
InventorsKlaus M Esser, Martin Rosenberg, Ruth Tal-Singer, Gary Woodnutt, Francis V Chisari, Susan B Dillon
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the use of compositions comprising IL-18, also known as interferon-γ-inducing factor (IGIF), and IL-18 in combination with other agents, for the prevention and/or treatment of viral diseases caused by HIV, HSV, HPV, HAV, HBV, and HCV.
Claims10
A method of treating a disease caused by Influenza Virus, HIV, HSV, HPV, HAV, HBV or HCV in a mammal comprising the administration of a therapeutically effective amount of a composition comprising a polypeptide having at least 90% identity of the amino acid sequence of SEQ ID NO:1 over the entire length of SEQ ID NO:1.
A method of treating a disease caused by Influenza Virus, HIV, HSV, HPV, HAV, HBV or HCV in a mammal comprising the administration of a therapeutically effective amount of a composition comprising a polypeptide having at least 90% identity of the amino acid sequence of SEQ ID NO:2 over the entire length of SEQ ID NO:2.
Dependencies are inferred from the claim text.